By vgreene, 3 March, 2021 Regional differences in efficacy of the Janssen vaccine were noted w the highest efficacy seen in the US 74 4 followed by Latin America 64 7 and South Africa 52 0 Regional differences in circulating virus variants were also noted in South Africa 94 5 were
By vgreene, 3 March, 2021 Janssen s vector based COVID 19 vaccine was 67 effective overall in preventing moderate to severe critical COVID 19 14 days after vaccination and 66 effective in preventing moderate to severe critical COVID 19 at 28 days after vaccination per the FDA s an
By vgreene, 3 March, 2021 Besides being used in vaccines viral vectors have also been studied for gene therapy to treat cancer for molecular biology research
By vgreene, 3 March, 2021 Viral vector vaccines have been well studied in clinical trials used to respond to recent Ebola outbreaks
By vgreene, 3 March, 2021 The genetic material delivered by the viral vector doesn t integrate into a person s DNA
